Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Immunology and Microbiology
Influenza
100%
Vaccine Efficacy
90%
Influenza Vaccine
62%
Vaccination Policy
56%
Virosome
35%
Immunogenicity
33%
Immune Response
30%
Virus Inactivation
30%
Influenza Virus
25%
Mouse
25%
Cytotoxic T Cell
24%
Adjuvant
24%
Subunit Vaccine
22%
T Cell
19%
Adoptive Immunity
19%
Antibody Response
17%
Influenza A Virus (H5N1)
15%
COVID-19
14%
Inactivated Virus Vaccine
12%
Influenza A Virus (H1N1)
12%
Dendritic Cell
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Antigen
11%
Peripheral Blood Mononuclear Cell
11%
Nucleoprotein
9%
Membrane Fusion
9%
Humoral Immunity
9%
Systemic Lupus Erythematosus
9%
B Cell
9%
Neutralizing Antibody
8%
Titer
8%
Monospecific Antibody
8%
Viral Disease
8%
Hemagglutination Inhibition
7%
Dry Powder
7%
Viral Envelope
7%
Virus-Like Particle
7%
Heat Shock
7%
Granulomatosis with Polyangiitis
7%
Hemagglutinin
7%
MHC Class I
6%
Toll-Like Receptor
6%
Antibody Titer
6%
Immunotherapy
6%
Antigen-Presenting Cell
6%
Virus Strain
6%
interferon
5%
Influenza A Virus (H3N2)
5%
Glycoprotein
5%
Cross Protection
5%
Pharmacology, Toxicology and Pharmaceutical Science
Influenza Vaccine
45%
Vaccination Policy
38%
Mouse
31%
Live Attenuated Influenza Vaccine
30%
Virosome
28%
Immunogenicity
26%
Adjuvant
25%
Subunit Vaccine
24%
Influenza Virus
23%
Infection
15%
Powder Formulation
13%
Inactivated Virus Vaccine
12%
SARS Coronavirus
12%
Inulin
10%
Influenza A Virus (H5N1)
10%
Antigen
10%
Disease
9%
Bagg Albino Mouse
8%
Trehalose
8%
Respiratory Tract
8%
Antivirus Agent
7%
Hemagglutinin
7%
Influenza A (H5N1)
7%
Virus Infection
6%
Saponin
6%
Immunoglobulin A
5%
Phosphoryl Lipid A
5%
Influenza A Virus (H1N1)
5%
Normal Human
5%
Keyphrases
Influenza Vaccine
17%
Influenza
11%
Influenza Vaccination
10%
Whole Inactivated Virus
8%
Lung
6%
Virus
6%
Immune Response
6%
Vaccination
5%
